The Essential Elements of Local Public Health provides updates and information from NACCHO’s Environmental Health and Infectious Disease portfolios.
New data further shows an injectable antiretroviral for HIV pre-exposure prophylaxis (PrEP) is safe and highly effective in reducing...
Jul 08, 2020 | Julia Zigman
The AIDS Clinical Trials Group, funded by the National Institute of Allergy and Infectious Diseases (NIAID), has started the first...
Jan 29, 2020 | Kim Rodgers
A new study from Karlstad University evaluated the association between early pregnancy exposure to eight Perfluoroalkyl substances...
Dec 21, 2019 | Michelle Shapiro
Researchers at University of Alabama at Birmingham (UAB) were awarded a grant by National Institute of Health’s National Institute of...
Nov 13, 2019 | Kim Rodgers
In a new commentary in Clinical Infectious Diseases, National Institutes of Health (NIH) experts suggest that ending HIV will require...
Oct 28, 2019 | Kim Rodgers
On June 13, 2019, a joint HHS/CDC/NIH/FDA webinar was held, focused on emerging issues in tickborne diseases. Agenda: Dr. Paul Mead,...
Jul 23, 2019 | Michelle Shapiro
May 18th marked HIV Vaccine Awareness Day (HVAD), a health observance recognizing the researchers, health professionals, activists,...
May 20, 2019 | Kim Rodgers
The National Institutes of Health has launched the Long-Acting Therapy to Improve Treatment Success in Daily Life (LATITUDE) study,...
The National Institute of Allergy and Infectious Diseases at the National Institutes of Health has announced awards to establish four...
New data further shows an injectable antiretroviral for HIV pre-exposure prophylaxis (PrEP) is safe and highly effective in reducing HIV risk cisgender men and transgender women who have sex with men.
The AIDS Clinical Trials Group, funded by the National Institute of Allergy and Infectious Diseases (NIAID), has started the first clinical trial testing a combined method of anti-HIV antibodies plus a long-acting antiretroviral medication as long-acting HIV treatment. Researchers are exploring the use of HIV antibodies for their potential to stop a wide variety of […]
A new study from Karlstad University evaluated the association between early pregnancy exposure to eight Perfluoroalkyl substances (PFAS) compounds respectively and birth weight in 1,533 mother child pairs in the Swedish Environmental Longitudinal, Mother and child, Asthma and allergy (SELMA) study, specifically focusing on differences according to sex of the child. Researchers found significant...
Researchers at University of Alabama at Birmingham (UAB) were awarded a grant by National Institute of Health’s National Institute of Allergy and Infectious Diseases (NIAID) to explore the efficacy of the vaccine, Bexsero, in protecting against infection with bacteria that causes gonorrhea.
In a new commentary in Clinical Infectious Diseases, National Institutes of Health (NIH) experts suggest that ending HIV will require optimizing implementation of existing HIV prevention and treatment tools, as well as the continued development of new interventions.
On June 13, 2019, a joint HHS/CDC/NIH/FDA webinar was held, focused on emerging issues in tickborne diseases. Agenda: Dr. Paul Mead, CDC—Welcome and introduction Denise Bonilla, USDA/APHIS—Update on the Asian longhorned tick (H. longicornis) Dr. William Nicholson, CDC—Alpha-gal allergy following tick bite: What do we really know? Dr. Kevin Esvelt, MIT—Mice against ticks: A community-guided...
May 18th marked HIV Vaccine Awareness Day (HVAD), a health observance recognizing the researchers, health professionals, activists, and volunteers involved in advancing HIV vaccine research. See the resources below that have been developed in honor of HVAD 2019: Blogs HIV.gov: HIV Vaccine Awareness Day 2019, by Anthony Fauci, M.D., Director, National Institute of Allergy and […]
The National Institutes of Health has launched the Long-Acting Therapy to Improve Treatment Success in Daily Life (LATITUDE) study, which compares monthly injectable antiretroviral therapy to daily oral drugs in people unable to adhere to strict daily regimens. The trial is funded by the National Institute of Allergy and Infectious and will be conducted by […]
The National Institute of Allergy and Infectious Diseases at the National Institutes of Health has announced awards to establish four Cooperative Research Centers (CRCs) focused on developing vaccines to prevent sexually transmitted infections. The grants, totaling $41.6 million over five years, will support collaborative, multidisciplinary research on the bacteria that cause syphilis, gonorrhea...
Create an account or login to MyNACCHO and go to "My Subscriptions."
Calendar
Empowering Public Health Through Law and Policy
Register
Join our impactful webinar to explore community-centered strategies for combating the opioid crisis.
The largest convening of local health department leaders and public health professionals in the United States.
NACCHO, with support from the Centers for Disease Control and Prevention (CDC), released a funding opportunity for The Improving...
Feb 12, 2024 | Tori Decea
The EPA's Small Communities, Big Challenges Competition encourages local governments to demonstrate their innovative strategies, from...
Nov 16, 2023 | Anu Varma
Celebrate with us!
Oct 12, 2023 | Anu Varma
Sep 11, 2023 | Irene Halferty, Kristen Ross
Sep 08, 2023 | Irene Halferty, Kristen Ross
The Building Local Operational Capacity for COVID-19, Healthcare-Associated Infections, and Antimicrobial Resistance (BLOC COVID-19+)...
Aug 14, 2023 | Irene Halferty, Kristen Ross
The Preparedness Brief provides updates and information from NACCHO’s public health preparedness portfolio.
This blog embodies NACCHO's mission to empower local health departments and drive positive change.
Stories from the Field provides a means for local health departments to share their experiences and demonstrate the value of public health.
The NACCHO website uses cookies to offer our visitors a better browsing experience, to analyze our website traffic, and to present personalized content; cookies are small data files that are attached to your computer when you visit websites. You can read about how we use cookies by clicking on the "details" button below. If you continue to use this website, you are consenting to our use of cookies.